TZAC: Tenzing Acquisition Corp. - Summary | Jitta

Tenzing Acquisition Corp.

NASDAQ:TZAC

Notice
Stock data is unavailable or the company’s delisted.
Price
$8.75
Loss Chance
58.4%
0.58JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (14)
Financial Strength (19)
Return to Shareholders (12)
Competitive Advantage (8)
Jitta Signs
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 4.76% in the last year
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.58
100.00%
2.12
311.43%
2.12
311.43%
2.17
100.00%
4.18
14.82%
3.14
44.53%
COMPANY DESCRIPTION
As of December 14, 2020, Tenzing Acquisition Corp. was acquired by Reviva Pharmaceuticals, Inc., in a reverse merger transaction. Tenzing Acquisition Corp. does not have significant operations. It intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities primarily operates in India. The company was founded in 2018 and is based in New York, New York.